Detalhe da pesquisa
1.
Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series.
Am J Kidney Dis
; 83(3): 340-349.e1, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37777061
2.
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
Am J Kidney Dis
; 83(5): 588-600.e1, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38151224
3.
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
Am J Kidney Dis
; 74(2): 224-238, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30929851
4.
Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
Am J Nephrol
; 41(1): 16-27, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25612603
5.
Accelerating the Depletion of Circulating Anti-Phospholipase A2 Receptor Antibodies in Patients with Severe Membranous Nephropathy: Preliminary Findings with Double Filtration Plasmapheresis and Ofatumumab.
Nephron
; 144(1): 30-35, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31336376
6.
Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation.
J Transplant
; 2012: 426042, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22685630